D. Allen Annis

3.1k total citations
26 papers, 1.4k citations indexed

About

D. Allen Annis is a scholar working on Molecular Biology, Oncology and Spectroscopy. According to data from OpenAlex, D. Allen Annis has authored 26 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 8 papers in Oncology and 5 papers in Spectroscopy. Recurrent topics in D. Allen Annis's work include Chemical Synthesis and Analysis (9 papers), Ubiquitin and proteasome pathways (7 papers) and Cancer-related Molecular Pathways (5 papers). D. Allen Annis is often cited by papers focused on Chemical Synthesis and Analysis (9 papers), Ubiquitin and proteasome pathways (7 papers) and Cancer-related Molecular Pathways (5 papers). D. Allen Annis collaborates with scholars based in United States, Sweden and France. D. Allen Annis's co-authors include Eric N. Jacobsen, Michael R. Ziebell, Charles E. Whitehurst, Elliot Nickbarg, Huw M. Nash, Xianshu Yang, Manuel Aivado, Vincent Guerlavais, Cheng‐Chi Chuang and Naim Nazef and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Journal of Clinical Oncology.

In The Last Decade

D. Allen Annis

26 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Allen Annis United States 19 863 430 269 180 172 26 1.4k
Alessandra Tolomelli Italy 28 1.5k 1.7× 1.2k 2.9× 155 0.6× 103 0.6× 121 0.7× 124 2.5k
Arno F. Spatola United States 26 1.4k 1.7× 801 1.9× 292 1.1× 125 0.7× 179 1.0× 79 2.2k
Marina I. Nelen United States 17 488 0.6× 472 1.1× 95 0.4× 87 0.5× 195 1.1× 27 1.2k
Lora Hamuro United States 23 2.0k 2.3× 510 1.2× 238 0.9× 100 0.6× 254 1.5× 47 2.7k
Paul W. Baures United States 20 659 0.8× 586 1.4× 138 0.5× 162 0.9× 119 0.7× 55 1.3k
Sara Pellegrino Italy 24 923 1.1× 585 1.4× 129 0.5× 75 0.4× 61 0.4× 124 1.7k
Zhaopeng Liu China 25 849 1.0× 869 2.0× 241 0.9× 154 0.9× 86 0.5× 127 2.1k
Svetlana Gramatikova United States 10 823 1.0× 304 0.7× 96 0.4× 85 0.5× 77 0.4× 14 1.3k
Matthew W. D. Perry Sweden 19 834 1.0× 513 1.2× 179 0.7× 68 0.4× 68 0.4× 34 1.4k

Countries citing papers authored by D. Allen Annis

Since Specialization
Citations

This map shows the geographic impact of D. Allen Annis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Allen Annis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Allen Annis more than expected).

Fields of papers citing papers by D. Allen Annis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Allen Annis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Allen Annis. The network helps show where D. Allen Annis may publish in the future.

Co-authorship network of co-authors of D. Allen Annis

This figure shows the co-authorship network connecting the top 25 collaborators of D. Allen Annis. A scholar is included among the top collaborators of D. Allen Annis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Allen Annis. D. Allen Annis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Xiaolei, Madhurendra Singh, Gema Sanz, et al.. (2021). Pharmacologic Activation of p53 Triggers Viral Mimicry Response Thereby Abolishing Tumor Immune Evasion and Promoting Antitumor Immunity. Cancer Discovery. 11(12). 3090–3105. 113 indexed citations
2.
Saleh, Mansoor N., Manish R. Patel, Todd M. Bauer, et al.. (2021). Phase 1 Trial of ALRN-6924, a Dual Inhibitor of MDMX and MDM2, in Patients with Solid Tumors and Lymphomas Bearing Wild-type TP53. Clinical Cancer Research. 27(19). 5236–5247. 110 indexed citations
3.
Woodfield, Sarah E., Yan Shi, Roma H. Patel, et al.. (2021). MDM4 inhibition: a novel therapeutic strategy to reactivate p53 in hepatoblastoma. Scientific Reports. 11(1). 2967–2967. 24 indexed citations
4.
Blay, Vincent, Irene Otero‐Muras, & D. Allen Annis. (2020). Solving the Competitive Binding Equilibria between Many Ligands: Application to High-Throughput Screening and Affinity Optimization. Analytical Chemistry. 92(18). 12630–12638. 5 indexed citations
5.
Prudent, Renaud, D. Allen Annis, Peter J. Dandliker, Jean‐Yves Ortholand, & Didier Roche. (2020). Exploring new targets and chemical space with affinity selection-mass spectrometry. Nature Reviews Chemistry. 5(1). 62–71. 58 indexed citations
6.
7.
Shustov, Andrei R., Amitkumar Mehta, Lubomir Sokol, et al.. (2018). Pseudoprogression (PsP) in Patients with Peripheral T-Cell Lymphoma (PTCL) Treated with the Novel Stapled Peptide ALRN-6924, a Dual Inhibitor of MDMX and MDM2. Blood. 132(Supplement 1). 5348–5348. 4 indexed citations
8.
Shustov, Andrei R., Steven M. Horwitz, Jasmine Zain, et al.. (2018). Preliminary Results of the Stapled Peptide ALRN-6924, a Dual Inhibitor of MDMX and MDM2, in Two Phase IIa Dose Expansion Cohorts in Relapsed/Refractory TP53 Wild-Type Peripheral T-Cell Lymphoma. Blood. 132(Supplement 1). 1623–1623. 7 indexed citations
9.
Mehta, Amitkumar, Sanjay Goel, Jasmine Zain, et al.. (2017). Phase 2a study of a novel stapled peptide ALRN-6924 disrupting MDMX- and MDM2-mediated inhibition of wild-type TP53 in patients with peripheral t-cell lymphoma. Annals of Oncology. 28. v370–v370. 8 indexed citations
10.
Meric‐Bernstam, Funda, Mansoor N. Saleh, Jeffrey R. Infante, et al.. (2017). Phase I trial of a novel stapled peptide ALRN-6924 disrupting MDMX- and MDM2-mediated inhibition of WT p53 in patients with solid tumors and lymphomas.. Journal of Clinical Oncology. 35(15_suppl). 2505–2505. 62 indexed citations
11.
Shi, Xiangguo, et al.. (2013). Hydrogen Exchange-Mass Spectrometry Measures Stapled Peptide Conformational Dynamics and Predicts Pharmacokinetic Properties. Analytical Chemistry. 85(23). 11185–11188. 18 indexed citations
12.
Sheth, Payal R., Gerald W. Shipps, Wolfgang Seghezzi, et al.. (2010). Novel Benzimidazole Inhibitors Bind to a Unique Site in the Kinesin Spindle Protein Motor Domain. Biochemistry. 49(38). 8350–8358. 25 indexed citations
13.
Calzada, Marı́a J., Светлана А. Кузнецова, John M. Sipes, et al.. (2008). Calcium indirectly regulates immunochemical reactivity and functional activities of the N-domain of thrombospondin-1. Matrix Biology. 27(4). 339–351. 18 indexed citations
14.
Annis, D. Allen, Elliot Nickbarg, Xianshu Yang, Michael R. Ziebell, & Charles E. Whitehurst. (2007). Affinity selection-mass spectrometry screening techniques for small molecule drug discovery. Current Opinion in Chemical Biology. 11(5). 518–526. 158 indexed citations
15.
Annis, D. Allen, Gerald W. Shipps, Yongqi Deng, et al.. (2007). Method for Quantitative Protein−Ligand Affinity Measurements in Compound Mixtures. Analytical Chemistry. 79(12). 4538–4542. 37 indexed citations
16.
Whitehurst, Charles E., Naim Nazef, D. Allen Annis, et al.. (2006). Discovery and Characterization of Orthosteric and Allosteric Muscarinic M2 Acetylcholine Receptor Ligands by Affinity Selection–Mass Spectrometry. SLAS DISCOVERY. 11(2). 194–207. 24 indexed citations
17.
Annis, D. Allen, Krishna Kalghatgi, Huw M. Nash, et al.. (2004). An affinity selection–mass spectrometry method for the identification of small molecule ligands from self-encoded combinatorial libraries. International Journal of Mass Spectrometry. 238(2). 77–83. 74 indexed citations
18.
19.
Annis, D. Allen & Eric N. Jacobsen. (1999). Polymer-Supported Chiral Co(Salen) Complexes:  Synthetic Applications and Mechanistic Investigations in the Hydrolytic Kinetic Resolution of Terminal Epoxides. Journal of the American Chemical Society. 121(17). 4147–4154. 359 indexed citations
20.
Annis, D. Allen, et al.. (1998). Stereochemische Eigenschaften als Diversitätselement: Festphasensynthese cyclischer RGD-Peptidderivate via asymmetrische Katalyse. Angewandte Chemie. 110(13-14). 2010–2012. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alessandra Tolomelli Breakdown of academic impact, for papers by Arno F. Spatola Breakdown of academic impact, for papers by Marina I. Nelen Breakdown of academic impact, for papers by Lora Hamuro Breakdown of academic impact, for papers by Paul W. Baures Breakdown of academic impact, for papers by Sara Pellegrino Breakdown of academic impact, for papers by Zhaopeng Liu Breakdown of academic impact, for papers by Svetlana Gramatikova Breakdown of academic impact, for papers by Matthew W. D. Perry
Rankless by CCL
2026